2. Lipids
  3. Isotope-Labeled Lipids
  4. Isotope-Labeled Sphingolipids
  5. Isotope-Labeled Neutral Glycosphingolipids

Isotope-Labeled Neutral Glycosphingolipids

Isotope-Labeled Neutral Glycosphingolipids (7):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N7745S1
    Glucosylsphingosine-d5 99.0%
    Glucosylsphingosine-d5 is the deuterium labeled Glucosylsphingosine.
    Glucosylsphingosine-d<sub>5</sub>
  • HY-N7745S
    Glucosylsphingosine-d7 2315262-29-2 99.04%
    Glucosylsphingosine-d7 is deuterium labeled Glucosylsphingosine.
    Glucosylsphingosine-d<sub>7</sub>
  • HY-N10634S
    D-Glucosyl-β-N-palmitoylsphingosine-d3 71924-12-4
    D-Glucosyl-β-N-palmitoylsphingosine-d3 (N-ω-CD3-Hexadecaoyl-glucopsychosie) is deuterium labeled D-Glucosyl-β-1,1′-N-palmitoylsphingosine (HY-N10634). D-Glucosyl-β-1,1′-N-palmitoylsphingosine (C16 Glucosyl(β) Ceramide (d18:1/16:0)) is an endogenous Mincle ligand possessing immunostimulatory activity.
    D-Glucosyl-β-N-palmitoylsphingosine-</sub>d<sub>3</sub>
  • HY-N7745S2
    Glucosylsphingosine-13C6 299172-48-8 98%
    Glucosylsphingosine-13C6 (Glucopsychosine-13C6) is the 13C-labeled Glucosylsphingosine (HY-N7745). Glucosylsphingosine (lyso-Gb1) is a deacylated form of glucosylceramide with neurotoxicity and is also a noncompetitively inhibitor of glucocerebrosidase with a Ki value of 30 μM. Glucosylsphingosine is promising for research of Krabbe and Gaucher disease.
    Glucosylsphingosine-<sup>13</sup>C<sub>6</sub>
  • HY-153830S
    LacCer (d18:1/16:0)-d3 2097249-92-6
    LacCer (d18:1/16:0) (C16 Lactosylceramide (d18:1/16:0))-d3 is the deuterium labeled LacCer (d18:1/16:0) (HY-153830). LacCer (d18:1/16:0) is an endogenous bioactive sphingolipid that can form membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs). LacCer (d18:1/16:0) are elevated in the plasma of insulin-resistant cattle. LacCer (d18:1/16:0) is also upregulated in a mouse model of Niemann-Pick type C1 disease (a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder). LacCer (d18:1/16:0) can be used in research on metabolic diseases and neurodegenerative diseases.
    LacCer (d18:1/16:0)-d<sub>3</sub>
  • HY-146923S
    D-Lactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine-d7 2770684-31-4
    D-Lactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine-d7 is deuterium labeled D-Lactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine.
    D-Lactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine-d<sub>7</sub>
  • HY-146922S
    D-Galactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine-d7 2770684-23-4
    D-Galactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine-d7 is deuterium labeled D-Galactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine.
    D-Galactosyl-ß-1,1' N-nervonoyl-D-erythro-sphingosine-d<sub>7</sub>